Newsroom Stories

The largest gift in WashU history, from the Bursky Family Foundation, will advance the School of Public Health’s vision in a post-pandemic world.

A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant helps prevent toxic side effects and potentially improves the effectiveness of therapies.

As editor-in-chief of Organization Science, WashU Olin Business School’s Lamar Pierce is sounding the alarm about the increasing strain on the peer review system caused by artificial intelligence and university incentives.

A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.

WashU researchers led a population-based study of thousands of college students showing that a phone app with text coaching increased access to care and eased symptoms of depression, anxiety and eating disorders.

WashU McKelvey Engineering researchers have mapped out how to create artificial intelligence machines for solving problems with potentially trillions of complicating factors.

Researchers at WashU McKelvey Engineering are addressing the challenges of scaling up carbon dioxide electrolysis for industrial use.

The late James McLeod, vice chancellor for students and dean of the College of WashU Arts & Sciences, founded the Ervin Scholars Program and, along with his wife, Clara, challenged the WashU community to know each student “by name and by story.”

Will Arvin, vice chancellor for medical advancement at Washington University in St. Louis, has been appointed executive vice chancellor for advancement, effective Jan. 5, according to Chancellor Andrew D. Martin. Arvin will succeed Pamella A. Henson, who is retiring.

WashU Medicine researchers discovered a cellular mechanism that may protect some patients with a genetic lung condition from developing liver damage.